Very low level viraemia and risk of virological failure in treated <scp>HIV</scp>‐1‐infected patientsRamón Teira, Francesc Vidal, Pepa Muñoz-Sánchez et al.|HIV Medicine|2016Cited by 23
Pérdidas de seguimiento de personas con infección por el VIH en la cohorte española VACH en el periodo 2013-2014: importancia de los factores sociodemográficosRamón Teira, Pepa Muñoz-Sánchez, Núria Espinosa et al.|Enfermedades Infecciosas y Microbiología Clínica|2018Cited by 14
Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIVRamón Teira, Juan Berenguer, Helena Díaz-Cuervo et al.|PLoS ONE|2021Cited by 10
Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish CohortRamón Teira, Adrián Curran, Helena Díaz-Cuervo et al.|Infectious Diseases and Therapy|2022Cited by 6
Losses to follow-up of HIV-infected people in the Spanish VACH cohort over the period between 2013 and 2014: The importance of sociodemographic factorsRamón Teira, Pepa Muñoz-Sánchez, Núria Espinosa et al.|Enfermedades infecciosas y microbiologia clinica (English ed )|2019Cited by 3